Modified migration assay results made it possible to assume that gastric cancer cells might produce chemoattractant factors which induce the migration of HB1.F3.CD and HB1.F3.CD.IFN-β cells to cancer cells, resulting in the delivery of therapeutic genes to the tumor site. Here, IFNB1 is linked to cancer.